Omics Sequencing Market Revenue and Forecast by 2033

03 Sep 2025

Share :

Table of Content

1. Omics Sequencing Market Revenue and Trends 2025 to 2033 2. Key drivers enabling the growth of the Omics Sequencing Market 3. Segment Insights 4. Regional Insights 5. Omics Sequencing Market Coverage 6. Omics Sequencing Market Key Players

Omics Sequencing Market Revenue and Trends 2025 to 2033

The omics sequencing market is transforming healthcare by enabling deeper insights into genomics, transcriptomics, and proteomics for precision medicine. The omics sequencing market is rising due to growing demand for personalized medicine, advancements in genomic technologies, and increased government and private sector investments in life sciences research.

Key drivers enabling the growth of the Omics Sequencing Market

The omics sequencing market is a fast-growing market for a number of reasons that are driving this sector. First, technological advances including high-throughput sequencing, microfluidics, and more powerful and better bioinformatics solutions have lowered costs and improved the availability and accuracy of omics data, thereby increasing the efficiency of omics analysis and driving costs lower.

Second, the increase in personalized medicine is further driving growth as healthcare providers are increasingly relying on omics data to differentiate the care of patients with personalized patient-specific genetic based profiles to improve durability of therapeutics. Third, new types of development and applications of omics research in disease research (e.g. cancer, neurological disorders, rare genetic disorders, etc.) are enabling researchers to discover new biomarkers and drug targets.

Finally, government policies and increased public funding for genomics and multi-omics has fuelled significant new development and infrastructure which further establishes omics sequencing as a core component of contemporary biomedical research and precision health care.

Segment Insights

• By technology, Next-generation sequencing (NGS) takes the largest share of the market, fuelling advanced genomics, personalized medicine and advanced diagnostics in a high-throughput and economic environment.
• By component, the reagents and consumable segment dominates the market through significant demand for fast and reliable workflows and precision genomics using NGS.
• By application, the clinical diagnostics segment dominates the market with explosive growth in NGS adoption, precision medicine and early disease detection.
• By end-user, academic and research institutions lead the market through NGS technologies, for genomics studies, biomarker discovery and high-level research applications.
• By distribution model, the direct sales segment commands the market enabling manufacturers to bring NGS products directly to the global end-user efficiently.

Regional Insights

North America is the leading region in the global omics sequencing market, which can primarily be attributed to the advanced healthcare infrastructure, large amounts of research funding available and the application of precision medicine. Other contributing factors are the presence of major players, strong genomic research, and regulatory environments that promote the development of omics technologies.

The Asia-Pacific region is starting to become the fastest growing region in the omics sequencing market. This is due to government investments in biotechnology, the expanding biotechnology sector, and the increasing awareness of personal medicine. Rapid advances in healthcare infrastructure have significantly increased demand for genomic, and other omics, solutions, in China, India, Japan, and other countries in the region.

Omics Sequencing Market Coverage

Recent Developments

• In June 2025, at the BIO International Convention in Boston, MGI Tech unveiled its advanced PanOmiQ platform, targeting precision medicine and genomic research. (Source: https://www.biospace.com)

Omics Sequencing Market Key Players

• 10x Genomics
• Agilent Technologies
• BGI Group/MGI Tech Co.
• Bio-Rad Laboratories
• Bruker
• Danaher Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Illumina
• LGC Limited
• Merck KGaA
• New England Biolabs
• Novogene Co., Ltd.
• Oxford Nanopore Technologies plc
• Pacific Biosciences (PacBio)
• PerkinElmer
• Promega Corporation
• QIAGEN
• Takara Bio Inc.
• Thermo Fisher Scientific

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6701

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344